These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31231766)

  • 1. Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients.
    O'Brien DP; Friedman ND; Cowan R; Walton A; Athan E
    Clin Infect Dis; 2020 Apr; 70(9):1993-1997. PubMed ID: 31231766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Walton A; Athan E
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006357. PubMed ID: 29554101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
    O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
    PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
    Cowan R; Athan E; Friedman ND; Hughes AJ; McDonald A; Callan P; Fyfe J; O'Brien DP
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003503. PubMed ID: 25658304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study.
    Tweedale B; Collier F; Waidyatillake NT; Athan E; O'Brien DP
    PLoS One; 2023; 18(4):e0284201. PubMed ID: 37093836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
    Yotsu RR; Richardson M; Ishii N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
    Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.
    O'Brien DP; Friedman D; Hughes A; Walton A; Athan E
    Intern Med J; 2017 Sep; 47(9):1011-1019. PubMed ID: 28585259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Athan E
    PLoS Negl Trop Dis; 2014; 8(1):e2612. PubMed ID: 24392172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated with Antibiotic Treatment Failure of Buruli Ulcer.
    O'Brien DP; Friedman ND; Walton A; Hughes A; Athan E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.
    O'Brien DP; Robson M; Friedman ND; Walton A; McDonald A; Callan P; Hughes A; Rahdon R; Athan E
    BMC Infect Dis; 2013 Sep; 13():416. PubMed ID: 24007371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
    Friedman ND; Athan E; Hughes AJ; Khajehnoori M; McDonald A; Callan P; Rahdon R; O'Brien DP
    PLoS Negl Trop Dis; 2013; 7(7):e2315. PubMed ID: 23875050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.
    O'Brien DP; Murrie A; Meggyesy P; Priestley J; Rajcoomar A; Athan E
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007178. PubMed ID: 30779807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric Buruli ulcer in Australia.
    Walker G; Friedman DN; O'Brien MP; Cooper C; McDonald A; Callan P; O'Brien DP
    J Paediatr Child Health; 2020 Apr; 56(4):636-641. PubMed ID: 31821679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.
    O'Brien DP; Friedman ND; Cowan R; Pollard J; McDonald A; Callan P; Hughes A; Athan E
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004253. PubMed ID: 26630648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
    Tanywe A; Fernandez RS
    JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans.
    Sarfo FS; Phillips RO; Ampadu E; Sarpong F; Adentwe E; Wansbrough-Jones M
    Clin Vaccine Immunol; 2009 Jan; 16(1):61-5. PubMed ID: 19005025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.